Case Study: Novo Nordisk improves pharma partnering collaboration with Inpart

A Inpart Case Study

Preview of the Novo Nordisk Case Study

Novo Nordisk adds more teams and runs reports in seconds with Inpart

Novo Nordisk, a global pharmaceutical company, needed to improve the alignment and efficiency of its complex partnering initiatives across various internal teams, including Search & Evaluation, drug delivery, and digital health. The challenge was to centralize this process to foster better collaboration and manage a high volume of opportunities. To address this, they turned to the vendor Inpart and implemented its Deal platform, a solution designed specifically for life sciences partnering.

The Inpart Deal solution provided a centralized platform that standardized workflows for in-licensing, out-licensing, and collaborations, allowing teams to track project status and collaborate seamlessly. By integrating everyday tools and reducing manual data entry, Inpart enabled Novo Nordisk to work as one unified company. This resulted in improved internal alignment, faster reporting that took only seconds, and successful scaling of the solution to more departments, significantly advancing their strategic partnering opportunities.


View this case study…

Inpart

47 Case Studies